emtricitabine - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle AUST R: 326237Active ingredients:
emtricitabine
tenofovir disoproxil succinate
Dosage form:
Tablet, film coated
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
03 Nov 2023
to
01 Jul 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.
|
TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle AUST R: 265834Active ingredients:
emtricitabine
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
20 May 2024
to
31 Jan 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.
|
Tenofovir/Emtricitabine 300/200 ARX tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack AUST R: 275070Active ingredients:
emtricitabine
tenofovir disoproxil fumarate
Dosage form:
Tablet, film coated
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
31 Jan 2025
to
25 Apr 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.
|
CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack AUST R: 327898Active ingredients:
emtricitabine
tenofovir disoproxil fumarate
Dosage form:
Tablet, film coated
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
01 Aug 2024
to
15 Nov 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|